
December 12, 2022
•
1 min read
1st Prize in the Innovinc. RBC – Esquissez 2022 Final
mTatt is proud to announce its success at the Innovinc. RBC — Esquissez competition, an event dedicated to empowering student and graduate entrepreneurs from the Université de Montréal. After presenting its vision for revolutionizing health monitoring with a microneedle patch, mTatt was awarded a $2,500 grant and $375 in legal services to fuel the company’s development.
About Innovinc. RBC — Esquissez
Organized by Innovinc. Société Innovante, this program supports early-stage ventures by offering mentorship, resources, and funding opportunities. It provides a platform for students to validate and accelerate their business ideas, helping shape the next generation of entrepreneurs in Quebec.About mTatt: mTatt is a health technology startup developing a groundbreaking microneedle patch for continuous, non-invasive monitoring of biomarkers such as hormones, NT-proBNP, cholesterol, and more. Our mission is to provide real-time health insights to enable earlier detection, personalized treatment, and improved patient outcomes.
Disclaimer: The mTatt patch is currently under development, has not been approved by regulatory authorities, and is not yet available for sale in any geography.
Contact: Samuel Babity — Co-Founder and CEO
Sources: Innovinc. RBC